Intelligent Particle Therapy for Personalized Cardiac Arrhythmia Treatment

This inventive concept envisions a next-generation particle therapy system that leverages machine learning, real-time imaging, and adaptive radiation delivery to provide personalized, precise, and effective treatment for cardiac arrhythmias, surpassing the limitations of current particle therapy approaches.

The original patent disclosed a system and method for carbon particle therapy for treating cardiac arrhythmias, which relied on mapping and gating to compensate for tissue movement. However, this approach has limitations, such as reduced accuracy due to imperfect motion prediction and potential collateral damage. The new inventive concept addresses these limitations by incorporating advanced technologies to enable real-time adaptation, precision targeting, and personalized treatment.

The proposed system comprises a machine learning-based motion prediction module, a real-time adaptive radiation delivery module, and a multi-modal imaging module for simultaneous acquisition of cardiac movement data and high-resolution anatomical images. The system enables personalized treatment planning using patient-specific, 3D-printed cardiac models and integrates machine learning-based cardiac motion forecasting with real-time radiation beam adjustment. Additionally, a wearable cardiac monitoring device tracks cardiac movement and transmits real-time data to the radiation therapy system for adaptive radiation delivery.

The new inventive concept introduces a paradigm shift in particle therapy by integrating machine learning, real-time imaging, and adaptive radiation delivery, enabling unprecedented precision, personalization, and effectiveness in treating cardiac arrhythmias. The combination of these advanced technologies and the wearable cardiac monitoring device constitutes a novel and non-obvious invention.

Alternative embodiments of the inventive concept could include using different machine learning algorithms, incorporating additional imaging modalities, or integrating with other treatment modalities, such as electrophysiology or pharmacological interventions. Variations could also include adapting the system for treating other diseases or conditions, such as cancer or neurological disorders.

The proposed inventive concept has significant commercial potential in the radiation oncology and cardiology markets, with potential applications in hospitals, clinics, and research institutions. The system's ability to provide personalized, precise, and effective treatment for cardiac arrhythmias could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.